| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $17.2M | -39.4% | -58.8% |
| R&D Expense | $23.3M | -21.3% | -40.6% |
| SG&A Expense | $10.4M | +0.6% | -21.7% |
| Operating Income | -$16.5M | -42.1% | -53.8% |
| Pre-tax Income | -$13.4M | -46.6% | -88.9% |
| Income Tax | $4K | +0.0% | +101.8% |
| Net Income | -$13.4M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $180.4M | -8.2% | -24.0% |
| Accounts Receivable | $8.0M | -53.8% | -73.7% |
| Current Assets | $249.2M | -9.2% | -24.7% |
| Total Assets | $282.3M | -8.7% | -23.8% |
| Current Liabilities | $31.7M | -31.9% | -54.4% |
| Total Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$58.0M | — | — |
| Capital Expenditures | $318K | — | — |
| Investing Cash Flow | -$318K | — | — |
| Financing Cash Flow | $1.7M | — | — |
| Free Cash Flow | -$58.4M | — | — |
| -46.5% |
| -94.8% |
| EPS (Basic) | -$0.49 | -44.1% | -88.5% |
| EPS (Diluted) | -$0.49 | -44.1% | -88.5% |
| $57.8M |
| -26.1% |
| -46.9% |
| Stockholders' Equity | $224.6M | -2.8% | -14.2% |